DrugPatentWatch Database Preview
Oxybutynin - Generic Drug Details
What are the generic drug sources for oxybutynin and what is the scope of oxybutynin freedom to operate?
Oxybutynin
is the generic ingredient in eight branded drugs marketed by Barr Labs Div Teva, Allergan Sales Llc, Par Pharm Inc, Ortho Mcneil Janssen, Apotex Inc, Lannett Co Inc, Mikart, Pharm Assoc, Wockhardt Bio Ag, Janssen Pharms, Accord Hlthcare, Amneal Pharms, Impax Pharms, Mylan, Mylan Pharms Inc, Osmotica Pharm Us, Unique Pharm Labs, Zydus Pharms Usa Inc, Abhai Llc, Appco Pharma Llc, Novitium Pharma, Quantum Pharmics, Teva Pharms Usa, Tulex Pharms Inc, Upsher-smith Labs, Usl Pharma, Vintage Pharms, and Watson Labs, and is included in thirty-three NDAs. There are eleven patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.There are sixteen drug master file entries for oxybutynin. Two suppliers are listed for this compound.
Summary for oxybutynin
| US Patents: | 11 |
| Tradenames: | 8 |
| Applicants: | 28 |
| NDAs: | 33 |
| Drug Master File Entries: | 16 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 58 |
| Clinical Trials: | 73 |
| Patent Applications: | 5,229 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for oxybutynin |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for oxybutynin |
| DailyMed Link: | oxybutynin at DailyMed |
Pharmacology for oxybutynin
| Drug Class | Cholinergic Muscarinic Antagonist |
| Mechanism of Action | Cholinergic Muscarinic Antagonists |
Synonyms for oxybutynin
| (+/-)-oxybutynin |
| (+/-)-OXYBUTYNIN(Hydrochloride form) |
| 1508-65-2 (hydrochloride) |
| 27815-EP2269989A1 |
| 27815-EP2275420A1 |
| 27815-EP2280008A2 |
| 27815-EP2298767A1 |
| 27815-EP2314587A1 |
| 4-(Diethylamino)-2-butynyl .alpha.-phenylcyclohexaneglycolate |
| 4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester |
| 4-(Diethylamino)-2-butynyl cyclohexyl(hydroxy)phenylacetate # |
| 4-(diethylamino)-2-butynyl-alpha-cyclohexyl-alpha-hydroxybenzeneacetate |
| 4-(diethylamino)-2-butynyl-alpha-phenylcyclohexaneglycolate |
| 4-(diethylamino)but-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate |
| 4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate |
| 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenyl-acetate |
| 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate |
| 4-Diethylamino-2-butinyl alpha-cyclohexylmandelat |
| 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate |
| 4-diethylaminobut-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate |
| 5633-20-5 |
| 633O205 |
| AB0013281 |
| AB2000274 |
| AC-2153 |
| AC1L1ILV |
| AK162584 |
| AKOS015896242 |
| AN-14276 |
| Anturol |
| Anturol (TN) |
| API0007236 |
| AX8146542 |
| BDBM50165019 |
| Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester |
| BPBio1_000214 |
| BRD-A65013509-003-03-8 |
| BSPBio_000194 |
| C-20821 |
| C07360 |
| CC-33425 |
| CCG-205005 |
| CCRIS 1923 |
| CHEBI:7856 |
| CHEMBL1231 |
| CS-2255 |
| Cyclohexaneglycolic acid, .alpha.-phenyl-, 4-(diethylamino)-2-butynyl ester |
| Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester |
| Cystrin |
| D00465 |
| D0F5LH |
| DB01062 |
| Ditropan |
| Ditropan Xl |
| Ditropan;Lyrinel XL;Oxytrol |
| DR001867 |
| DTXSID0023406 |
| FT-0082890 |
| FT-0603679 |
| GTPL359 |
| HSDB 3270 |
| HY-B0267 |
| I06-2117 |
| K-9978 |
| kentera |
| KS-00000GVI |
| KS-5221 |
| L000923 |
| Lopac0_000923 |
| LP048773 |
| LS-28714 |
| Lyrinel XL |
| MCULE-3407007074 |
| MFCD00865252 |
| MLS006010052 |
| MolPort-003-849-741 |
| MRF-0000601 |
| NCGC00015767-03 |
| NCGC00015767-04 |
| NCGC00015767-06 |
| NCGC00015767-07 |
| NCGC00015767-09 |
| NCGC00089795-02 |
| O222 |
| OR285581 |
| Oxibutinina |
| Oxibutinina [INN-Spanish] |
| Oxibutyninum |
| Oxybutinin |
| Oxybutynin (Ditropan) |
| Oxybutynin (USAN/INN) |
| Oxybutynin [USAN:INN:BAN] |
| Oxybutynin Base |
| oxybutynin topical gel |
| Oxybutynin transdermal |
| Oxybutynin transdermal patch |
| OXYBUTYNIN, Oxybutynin chloride |
| Oxybutynine |
| Oxybutynine [INN-French] |
| Oxybutyninum |
| Oxybutyninum [INN-Latin] |
| Oxytrol |
| Oxytrol (TN) |
| Pollakisu |
| Prestwick0_000287 |
| Prestwick1_000287 |
| Prestwick2_000287 |
| Prestwick3_000287 |
| s1754 |
| SBI-0050898.P002 |
| SC-26752 |
| SCHEMBL2992 |
| SMR001550466 |
| SPBio_002413 |
| ST24048863 |
| transdermal patch |
| XIQVNETUBQGFHX-UHFFFAOYSA-N |
US Patents and Regulatory Information for oxybutynin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tulex Pharms Inc | OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET;ORAL | 210125-001 | Sep 6, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Allergan Sales Llc | OXYTROL FOR WOMEN | oxybutynin | FILM, EXTENDED RELEASE;TRANSDERMAL | 202211-001 | Jan 25, 2013 | OTC | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Allergan Sales Llc | OXYTROL | oxybutynin | FILM, EXTENDED RELEASE;TRANSDERMAL | 021351-002 | Feb 26, 2003 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for oxybutynin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Allergan Sales Llc | OXYTROL FOR WOMEN | oxybutynin | FILM, EXTENDED RELEASE;TRANSDERMAL | 202211-001 | Jan 25, 2013 | ➤ Sign Up | ➤ Sign Up |
| Allergan Sales Llc | OXYTROL | oxybutynin | FILM, EXTENDED RELEASE;TRANSDERMAL | 021351-002 | Feb 26, 2003 | ➤ Sign Up | ➤ Sign Up |
| Allergan Sales Llc | OXYTROL FOR WOMEN | oxybutynin | FILM, EXTENDED RELEASE;TRANSDERMAL | 202211-001 | Jan 25, 2013 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for oxybutynin
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2004080413 | ➤ Sign Up |
| Mexico | PA05004110 | ➤ Sign Up |
| Argentina | 030312 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: